Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 59 min ago
PreprintAll rights reservedmedRxiv

Integrated Genomic and Immune Profiling Reveals PIK3CA-Mutant HPV16-Positive Cervical Cancer as a Clinically Aggressive and Immunologically Distinct Subtype in Patients from Eastern India

  • A. Ghosh
  • A. Ghosh
  • A. Sinha
  • S. Mathai
  • J. Bhaumik
  • A. Mukhopadhyay
  • S. Majumder
  • A. Maitra
  • N. K. Biswas
  • K. Mondal
  • P. P. Majumder
  • S. Sengupta1
  1. 1BRIC-National Institute of Biomedical Genomics, Kalyani, West Bengal, India; Saroj Gupta Cancer Centre & Research Institute, Kolkata, West Bengal, India
Read full textPDFDOICite

Related

  1. Integrated transcriptomic profiling identifies a clinically adverse iron-autophagy imbalance state in neuroblastoma.
    Li Zhang, Xiaomeng Wang, Zhanbo Wu +2
    Translational pediatricsPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMC
  2. New-onset Anti-melanoma Differentiation-associated Gene 5 Antibody Positive Clinically Amyopathic Dermatomyositis Following COVID-19
    Yu Nakanishi, Hirofumi Watanabe, Mako Tsuyuki +3
    Internal MedicinePeer-reviewedCC BY-NC-NDFull text1 citedEpidemiology & public healthJ-STAGE
  3. Genome mining, antibacterial activity, and metabolomic profiling reveal the biosynthetic potential of Burkholderia glumae isolates from Thailand with activity against clinically important bacterial pathogens
    Sujin Patarapuwadol, Panalee Oupaijit, Pornpavee Nualnisachol +2
    PLOS OnePeer-reviewedCC BYFull textEnzymology & metabolismProteomics & metabolomicsPLOSEurope PMCPMC
  4. Clinically low-risk features do not exclude diffusion-weighted imaging-positive lesions in suspected transient ischemic attack
    Leonhard Mann, Kayvan Ern, Simon Stahn +3
    Frontiers in NeurologyPeer-reviewedCC BY 4.0Full textEpidemiology & public healthCrossrefEurope PMCPMC
  5. [18F]FDG PET/CT-Derived Metabolic Characteristics and Tumour-Infiltrating Lymphocytes for Predicting Axillary Response to Neoadjuvant Chemo-(Immuno)Therapy in Clinically Node-Positive Breast Cancer
    Melissa Lenaerts, Loes F. S. Kooreman, Chris C. P. Adang +12
    CancersPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC

Cite

BibTeXRIS
BibTeX
@misc{ghosh2026integrated,
  title = {{Integrated Genomic and Immune Profiling Reveals PIK3CA-Mutant HPV16-Positive Cervical Cancer as a Clinically Aggressive and Immunologically Distinct Subtype in Patients from Eastern India}},
  author = {A. Ghosh and A. Ghosh and A. Sinha and S. Mathai and J. Bhaumik and A. Mukhopadhyay and S. Majumder and A. Maitra and N. K. Biswas and K. Mondal and P. P. Majumder and S. Sengupta},
  howpublished = {medRxiv},
  year = {2026},
  month = oct,
  doi = {10.64898/2026.10.27.26366457},
  url = {https://www.medrxiv.org/content/10.64898/2026.10.27.26366457v1},
}
RIS
TY  - UNPB
TI  - Integrated Genomic and Immune Profiling Reveals PIK3CA-Mutant HPV16-Positive Cervical Cancer as a Clinically Aggressive and Immunologically Distinct Subtype in Patients from Eastern India
AU  - A. Ghosh
AU  - A. Ghosh
AU  - A. Sinha
AU  - S. Mathai
AU  - J. Bhaumik
AU  - A. Mukhopadhyay
AU  - S. Majumder
AU  - A. Maitra
AU  - N. K. Biswas
AU  - K. Mondal
AU  - P. P. Majumder
AU  - S. Sengupta
PY  - 2026
DA  - 2026/10/27
PB  - medRxiv
DO  - 10.64898/2026.10.27.26366457
UR  - https://www.medrxiv.org/content/10.64898/2026.10.27.26366457v1
ER  -